Margarita Vallinas-Gonzalez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy.
Journal: Nutrition and cancer
Published: October 11, 2015
The ellagic acid derivative 4,4'-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 06, 2014
Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 07, 2014
Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer.
Journal: Molecular oncology
Published: January 16, 2014
Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancer.
Journal: PloS one
Published: January 03, 2014
Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells.
Journal: Electrophoresis
Published: November 14, 2013
Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives.
Journal: Nutrition reviews
Published: September 17, 2013
Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
Journal: Pharmacological research
Published: October 11, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026